Work

Abstract 2694: Dissecting the mechanisms of drug resistance development post neoadjuvant osimertinib treatment in EGFR-mutant non-small lung cancer.

Year: 2026
Type: conference-abstract
Institution: Yonsei University
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W7148721988
Cites:
Cited by:
Related to: